Intelligent Pain Management System using Synergistic Combinations
Legal Citation
Summary of the Inventive Concept
A novel system integrating a preservative-free intranasal composition of lidocaine with advanced technologies such as AI, IoT, blockchain, and new materials to provide personalized, optimized, and trackable pain management solutions.
Background and Problem Solved
The original patent disclosed a preservative-free intranasal composition of lidocaine for treating various pain conditions. However, it lacked the capabilities to monitor patient dosage, optimize treatment regimens, and provide personalized care. The new inventive concept addresses these limitations by combining the original composition with cutting-edge technologies to create a more effective and efficient pain management system.
Detailed Description of the Inventive Concept
The system comprises a preservative-free intranasal composition of lidocaine, a mechanical pump metered dose spray device, and a blockchain-based tracking system for monitoring patient dosage and treatment outcomes. Additionally, it incorporates an AI-powered diagnostic tool for identifying optimal dosage and treatment regimens, an IoT-enabled sensor for tracking patient vital signs, and a mobile application for remote monitoring and treatment adjustment. The system also utilizes a novel material composition for enhanced bioavailability and efficacy. Furthermore, it integrates a genetic testing platform for identifying genetic markers associated with pain sensitivity and an AI-powered treatment optimization algorithm for personalized pain management.
Novelty and Inventive Step
The new inventive concept introduces the synergistic combination of a preservative-free intranasal composition of lidocaine with advanced technologies, providing a novel and non-obvious solution for pain management. The integration of blockchain, AI, IoT, and new materials enables real-time monitoring, personalized treatment, and optimized outcomes, which is not disclosed in the original patent.
Alternative Embodiments and Variations
Alternative embodiments of the system may include using different AI algorithms, varying the type of IoT sensors, or incorporating additional technologies such as virtual or augmented reality. The system may also be adapted for use in different pain management applications, such as post-operative care or chronic pain management.
Potential Commercial Applications and Market
The Intelligent Pain Management System has significant commercial potential in the healthcare industry, particularly in the areas of pain management, telemedicine, and personalized medicine. The system's ability to provide optimized and trackable pain management solutions can improve patient outcomes, reduce healthcare costs, and increase market share for pharmaceutical companies and healthcare providers.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K31/167 |
| A | A61 | A61K9/0043 |
| A | A61 | A61M11/00 |
| A | A61 | A61M2210/0618 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical Device Technologies, Pharmaceutical Formulations, Pain Management Systems, with expertise in intranasal drug delivery, medical device design, and digital health technologies
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in pharmaceutical sciences, biomedical engineering, or related fields, possessing knowledge of drug delivery systems, medical device design, digital health technologies, and interdisciplinary medical innovation strategies
Obviousness Rationale
A PHOSITA would recognize that integrating digital technologies with established pharmaceutical formulations represents a predictable and incremental advancement in medical treatment. The source patent's preservative-free intranasal lidocaine composition provides a foundational platform for technological enhancement. The PTD's additions of AI, IoT, and tracking technologies represent logical extensions of existing medical technology trends toward personalized, data-driven healthcare solutions.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,520 |
|---|---|
| Title | Therapeutic composition of intranasal lidocaine |
| Assignee(s) | Nortic Holdings Inc. |